Short interest in Cencora Inc (NYSE:COR) decreased during the last reporting period, falling from 6.73M to 6.63M. This put 5.89% of the company's publicly available shares short. Short interest in ...

The indefinite idling of these facilities is not due to steel tariffs,” a company spokesperson said in a statement.

Hello, everyone, and thank you for joining the Cencora Fiscal 2025 Second Quarter Results Conference Call. My name is Lucy, and I will be coordinating your call today. [Operator Instructions] I ...

Cencora delivered a strong quarter with notable growth in the U.S. Healthcare Solutions segment, driven by specialty products and strategic investments. The company raised its full-year EPS ...

Cencora (COR) came out with quarterly earnings of $4.42 per share, beating the Zacks Consensus Estimate of $4.08 per share. This compares to earnings of $3.80 per share a year ago. These figures ...

CONSHOHOCKEN, Pa. (AP) — CONSHOHOCKEN, Pa. (AP) — Cencora, Inc. (COR) on Wednesday reported fiscal second-quarter profit of $717.9 million. On a per-share basis, the Conshohocken, Pennsylvania ...

May 7 (Reuters) - U.S. drug distributor Cencora (COR.N), opens new tab raised its annual profit forecast on Wednesday, driven by robust demand for costly specialty medicines and weight-loss drugs.